NCT01680159View on ClinicalTrials.gov

A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Plaque PsoriasisPsoriatic ArthritisPustular Psoriasis (Excluding a Localized)Psoriatic Erythroderma
Interventions
DRUG

TA-650

Trial Locations (7)

Unknown

Investigational site, Chugoku

Investigational site, Chūbu

Investigational site, Hokkaido

Investigational site, Kanto

Investigational site, Kinki

Investigational site, Kyushu

Investigational site, Tōhoku

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY